Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma.
Le Ngoc HaAmir IravaniNguyen Thi NhungNgo Thi Minh HanhFebby HutomoMai Hong SonPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2021)
The majority of recurrent or metastatic RAI-negative DTC have BRAFV600E mutation and detectable disease on FDG PET/CT. FDG avidity of the recurrent or metastatic RAI-negative DTC is independently associated with the aggressive histopathologic features.